Smith & Nephew plc

Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company focused on the repair, regeneration, and replacement of soft and hard tissue. The company's mission, encapsulated by "Life Unlimited," is to restore mobility, confidence, and quality of life through innovative orthopaedic and wound-care solutions, supporting healthcare professionals in improving patient lives. Its global headquarters are located in Watford, England.

Smith+Nephew operates through three primary global business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The Orthopaedics segment offers a range of hip, knee, and shoulder implants, alongside robotics-assisted surgical systems and trauma products. The Sports Medicine & ENT unit provides products for minimally invasive surgery and soft tissue repair, while Advanced Wound Management focuses on advanced treatments for complex wounds, including negative pressure wound therapy and specialized dressings. The company's products are sold in over 100 countries.

Under the leadership of CEO Dr. Deepak Nath and Chairman Rupert Soames, Smith+Nephew reported strong financial results for 2025, with revenue increasing by 6.1% to $6.16 billion and trading profit climbing 15.5% to $1.21 billion, following the completion of its "12-Point Plan" transformation. The company launched its new "RISE strategy" in December 2025, setting new financial targets for 2028, and expanded its portfolio with the acquisition of Integrity Orthopaedics in January 2026. Smith+Nephew holds a significant market position, including a notable share in the sports medicine market and being the second-largest globally in advanced wound care.